RBC Capital Reiterates Outperform on Sophia Genetics, Maintains $8 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Conor McNamara has reiterated an Outperform rating on Sophia Genetics (NASDAQ:SOPH) and maintained a price target of $8.
January 12, 2024 | 4:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital analyst Conor McNamara reaffirmed an Outperform rating on Sophia Genetics with a maintained price target of $8.
The reiteration of an Outperform rating by a major analyst like RBC Capital suggests a positive outlook on the stock, which could lead to increased investor confidence and potential upward movement in the short term. The maintained price target of $8 indicates the analyst's belief that the stock has the potential to reach or exceed this value, further supporting a positive short term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100